Avricore Health (AVCRF) EBT Margin (2015 - 2025)
Avricore Health (AVCRF) reported EBT Margin of 991.43% for Q3 2025, down 97680.0% year-over-year from N/an in Q3 2024, and up 39.39% quarter-over-quarter from 1635.67% in Q2 2025.
Avricore Health (AVCRF) EBT Margin (2015 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 11 years of EBT Margin data on file, last reported at 991.43% in Q3 2025.
- EBT Margin for Q3 2025 came in at 991.43%, down 97680.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 22.13% (down 1844.0% YoY), and the FY2025 annual result was 256.86%, down 25956.0% from the prior year.
- EBT Margin advanced to 991.43% in Q3 2025 per AVCRF's latest filing, from 1635.67% in the prior quarter.
- Over five years, EBT Margin peaked at 20.74% in Q1 2023 and troughed at 1635.67% in Q2 2025.
- A 5-year average of 277.72% and a median of 41.24% in 2022 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2021 and 2025: EBT Margin soared 361614 bps in 2021, then plunged 164086 bps in 2025.
- A 5-year view of EBT Margin shows it stood at 115.12% in 2021, then jumped by 79 bps to 24.43% in 2022, then soared by 121 bps to 5.07% in 2023, then tumbled by 388 bps to 14.63% in 2024, then tumbled by 6679 bps to 991.43% in 2025.
- Business Quant data shows AVCRF's EBT Margin at 991.43% in Q3 2025, 1635.67% in Q2 2025, and 17.3% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -6.95% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 15.76% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 20.75% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 31.16% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 22.23% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -12.17% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 7.90% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 14.39% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 22.14% |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -991.43% |
| Jun 30, 2025 | -1,635.67% |
| Mar 31, 2025 | -17.30% |
| Sep 30, 2024 | -14.63% |
| Jun 30, 2024 | 5.19% |
| Mar 31, 2024 | 14.10% |
| Dec 31, 2023 | 5.07% |
| Sep 30, 2023 | -29.59% |
| Jun 30, 2023 | -51.41% |
| Mar 31, 2023 | 20.74% |
| Dec 31, 2022 | -24.43% |
| Sep 30, 2022 | -31.06% |
| Jun 30, 2022 | -117.61% |
| Mar 31, 2022 | -434.88% |
| Dec 31, 2021 | -115.12% |
| Sep 30, 2021 | -125.50% |
| Jun 30, 2021 | -1,328.57% |
| Mar 31, 2021 | -126.85% |
| Dec 31, 2020 | -3,731.25% |
| Sep 30, 2020 | 380.88% |